Remdesivir rate volatility leads to claim rejections

Huge variations in the prices of Remdesivir — a crucial drug in the treatment of severe cases of Covid — have resulted in a large increase in insurance claim rejections and also black-listing of hospitals by insurance companies.

from Business News: Latest News on Business, Stock Markets, Financial News, India Business & World Business News https://ift.tt/3v4PIBR